Login / Signup

Core values of patients with advanced cancer considering participation in an early-phase clinical trial: a qualitative study.

Jelle L P van GurpLiza G G van LentNicole StoelCarin C D van der RijtMaja J A de JongeSaskia M PullemanJulia C M van WeertJeroen Hasselaar
Published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2022)
This article furthers the understanding of core values that play a role in the lives and decision-making of patients with advanced cancer who explore participation in early-phase clinical cancer trials. These values do not necessarily have to be compatible with one another, making tragic choices necessary. Understanding the role of core values can contribute to professional sensitivity regarding what motivates patients' emotions, thoughts, and decisions and help patients reflect on and give words to their values and preferences. It supports mutual understanding and dialog from which patients can make decisions according to their perspectives on a good life for themselves and their fellows in the context of participation in an early-phase clinical cancer trial.
Keyphrases
  • end stage renal disease
  • advanced cancer
  • clinical trial
  • ejection fraction
  • palliative care
  • chronic kidney disease
  • physical activity
  • patient reported outcomes
  • open label
  • phase ii
  • squamous cell